ALLE NORRIS: Open Payments
NPI 1649787227 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 56 payments from 17 companies in 2025. Trend: 2023 $1,799 · 2024 $1,590 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $162 |
| AstraZeneca Pharmaceuticals LP | 4 | $142 |
| Ferring Pharmaceuticals Inc. | 7 | $125 |
| Novo Nordisk Inc | 5 | $95 |
| Astellas Pharma US Inc | 3 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $80 |
| Lilly USA, LLC | 4 | $66 |
| ABBVIE INC. | 3 | $63 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Radius Health, Inc. | 2 | $54 |
Products named: FARXIGA, EUFLEXXA, ELIQUIS, Veozah, XIFAXAN, MOUNJARO, NEXLETOL, Wegovy.
Industry payments across LA — which companies pay providers there.
